Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women
Clinical trial NCT01631201 · COMPLETED
Trial details
- NCT number
- NCT01631201
- Sponsor
- ActivBiotics Pharma, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.